The digital diabetes developer Glooko has collected $100 million and a new CEO to help boost the trajectory of its data ...

Ono Pharmaceutical has bought a seat in a quiet corner of the congested antibody-drug conjugate (ADC) space, agreeing | Ono ...

Booster Therapeutics has launched with $15 million in seed financing and a mission to take on the current crop of targeted ...

Immatics has vaulted into phase 3 on the strength of early-stage data. The biotech is gearing up to start a pivotal trial of ...

Cytovale has raised $100 million in venture capital funding to support its rapid test for determining a patient’s sepsis risk ...

Gritstone bio may have left no stone unturned when it came to searching for a financial rescue, but the vaccine biotech has ...

Some six years after picking up Seattle’s Universal Cells for $102 million, Astellas Pharma is opening a second location for ...

Modex’s antibodies contain multiple binding sites and can target several parts of SARS-CoV-2’s spike protein, the tool the ...

Syneos Health has tapped Costa Panagos to take the reins from former CEO Colin Shannon, who will transition to the role of ...

Illumina is welcoming a new addition to its DNA sequencing lineup, with a pair of accessible benchtop instruments that ...

Join IQVIA in its Launch Excellence webinar, where we build on our Launch Excellence framework to explore challenges and key drivers of commercial success for new launches. New launches continue ...

After putting forward preliminary clinical data earlier this year from its neuromodulation implant for reducing chronic ...